For citations:

  Metabolic and antihypertensive effects of moxonidine and moxonidine plus irbesartan in patients with type 2 diabetes mellitus and mild hypertension: a sequential, randomized, double-blind clinical trial. Obesity and metabolism. 2008;5(4):61-62. (In Russ.) https://doi.org/10.14341/2071-8713-5236